International Journal of Multidisciplinary Research and Growth Evaluation  |  ISSN (Online): 2582-7138  |  Double-Blind Peer Review  |  Open Access  |  CC BY 4.0

Current Issues
     2026:7/3

International Journal of Multidisciplinary Research and Growth Evaluation

ISSN (Online): 2582-7138 | Open Access

Achieving Personalized Oncology Care: Insights and Challenges in Sub-Saharan Africa

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF)

Alternative download link

Abstract

Personalized oncology care, which involves tailoring cancer treatment to an individual patient's unique genetic, environmental, and lifestyle characteristics, has gained momentum globally as an effective strategy for improving cancer outcomes. However, implementing personalized oncology care in Sub-Saharan Africa presents significant challenges due to resource constraints, limited healthcare infrastructure, and sociocultural diversity. This review explores the insights and challenges surrounding personalized oncology care in the region, highlighting both opportunities and barriers. Key challenges include limited access to advanced diagnostic tools, such as genomic sequencing, which are essential for developing personalized treatment plans. Inadequate healthcare infrastructure and a shortage of trained oncology specialists exacerbate the difficulty of implementing precision medicine. Financial constraints, both at the patient and systemic levels, further limit access to innovative therapies and technologies. Additionally, sociocultural factors, including stigma and lack of awareness about cancer, hinder patient engagement and adherence to treatment. Despite these obstacles, innovative solutions are emerging. Collaborative efforts between governments, non-governmental organizations (NGOs), and international partners are driving advancements in cancer research and care delivery. Investments in telemedicine, mobile health platforms, and regional research initiatives have shown promise in bridging gaps in access and knowledge. Furthermore, localized cancer registries and biobanks are providing critical data to inform context-specific approaches to treatment. To achieve sustainable personalized oncology care in Sub-Saharan Africa, strategic investments in healthcare infrastructure, capacity building, and partnerships are essential. Addressing disparities in access to diagnostics and treatments, while fostering community engagement, will be critical for improving cancer outcomes in this resource-constrained region. This review underscores the urgent need for coordinated efforts to make personalized oncology care a reality in Sub-Saharan Africa.

How to Cite This Article

Kayode Ademola Matthew, Frank Nwaogelenya Opia, Ayodele Matthew, Abiodun Florence Kumolu, Temitayo Femi Matthew (2022). Achieving Personalized Oncology Care: Insights and Challenges in Sub-Saharan Africa . International Journal of Multidisciplinary Research and Growth Evaluation (IJMRGE), 3(1), 103-111. DOI: https://doi.org/10.54660/IJMRGE.2022.3.1.775-783

Export Citation:

BibTeX RIS EndNote

References

  1. 1. ratingthedevelopmentofpersonalizedcancerimmunotherapymathematicalmodels. Clin Pharmacol Ther.2020;108(3\:515-527.
  2. 2. Alfano CM, Jefford M, Maher J, Birken SA, Mayer DK. Buildingpersonalizedcancerfollow-upcarepathwaysinthe United States: lessonslearnedfromimplementationin England, Northern Ireland, and Australia. Am Soc Clin Oncol Educ Book.2019;39:625-639.
  3. 3. Anigilaje EA, Olutola A. Prospectsofgenetictestingforsteroid-resistantnephroticsyndromein Nigerianchildren: anarrativereviewofchallengesandopportunities. Int JNephrol Renovasc Dis.2019;12:119-136.
  4. 4. Aristei C, Perrucci E, Al?E, Marazzi F, Masiello V, Saldi S, etal. Personalizationinmodernradiationoncology: methods, resultsandpitfalls. Personalizedinterventionsandbreastcancer. Front Oncol.2021;11:616042.
  5. 5. Ayandipo O, Wone I, Kenu E, Fasehun LK, Ayandipo O, Gaye F, etal. Cancerecosystemassessmentin West Africa: healthsystemsgapstopreventandcontrolcancersinthreecountries: Ghana, Nigeria, and Senegal. Pan Afr Med J.2020;35(1\.
  6. 6. Baxi SM, Beall R, Yang J, Mackey TK. Amultidisciplinaryreviewofthepolicy, intellectualpropertyrights, andinternationaltradeenvironmentforaccessandaffordabilitytoessentialcancermedications. Glob Health.2019;15:1-14.
  7. 7. Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, etal. Artificialintelligenceincancerimaging: clinicalchallengesandapplications. CACancer JClin.2019;69(2\:127-157.
  8. 8. Boniolo F, Dorigatti E, Ohnmacht AJ, Saur D, Schubert B, Menden MP. Artificialintelligenceinearlydrugdiscoveryenablingprecisionmedicine. Expert Opin Drug Discov.2021;16(9\:991-1007.
  9. 9. Boyle P, Ngoma T, Sullivan R, Brawley O. Cancerin Africa: thewayforward. ecancermedicalscience.2019;13.
  10. 10. El-Rashidy N, El-Sappagh S, Islam SR, El-Bakry HM, Abdelrazek S. Mobilehealthinremotepatientmonitoringforchronicdiseases: principles, trends, andchallenges. Diagnostics(Basel\.2021;11(4\:607.
  11. 11. Epel ES, Crosswell AD, Mayer SE, Prather AA, Slavich GM, Puterman E, etal. Morethanafeeling: aunifiedviewofstressmeasurementforpopulationscience. Front Neuroendocrinol.2018;49:146-169.
  12. 12. Esther N, Julius S, Deogratius MA. Understandinghealth-seekingandadherencetotreatmentbypatientswithesophagealcanceratthe Uganda Cancer Institute: aqualitativestudy. BMCHealth Serv Res.2021;21:1-14.
  13. 13. Fadlelmola FM, Zass L, Chaouch M, Samtal C, Ras V, Kumuthini J, etal. Datamanagementplansinthegenomicsresearchrevolutionof Africa: challengesandrecommendations. JBiomed Inform.2021;122:103900.
  14. 14. Gill J, Fontrier AM, Miracolo A, Kanavos P. Accesstopersonalisedoncologyin Europe. London Schoolof Economics.2020.
  15. 15. Greaves RF, Bernardini S, Ferrari M, Fortina P, Gouget B, Gruson D, etal. Keyquestionsaboutthefutureoflaboratorymedicineinthenextdecadeofthe21stcentury: areportfromthe IFCC-Emerging Technologies Division. Clin Chim Acta.2019;495:570-589.
  16. 16. Gyasi RM, Phillips DR. Agingandtherisingburdenofnoncommunicablediseasesinsub-Saharan Africaandotherlow-andmiddle-incomecountries: acallforholisticaction. Gerontologist.2020;60(5\:806-811.
  17. 17. Hamdi Y, Zass L, Othman H, Radouani F, Allali I, Hanachi M, etal. Human OMICsandcomputationalbiologyresearchin Africa: currentchallengesandprospects. OMICS.2021;25(4\:213-233.
  18. 18. Hand T, Rosseau NA, Stiles CE, Sheih T, Ghandakly E, Oluwasanu M, etal. Theglobalrole, impact, andlimitationsof Community Health Workers(CHWs\inbreastcancerscreening: ascopingreviewandrecommendationstopromotehealthequityforall. Glob Health Action.2021;14(1\:1883336.
  19. 19. Hekler E, Tiro JA, Hunter CM, Nebeker C. Precisionhealth: theroleofthesocialandbehavioralsciencesinadvancingthevision. Ann Behav Med.2020;54(11\:805-826.
  20. 20. Hu C, Dignam JJ. Biomarker-drivenoncologyclinicaltrials: keydesignelements, types, features, andpracticalconsiderations. JCOPrecis Oncol.2019;1:1-12.
  21. 21. Hunter N, Dempsey N, Tbaishat F, Jahanzeb M, Al-Sukhun S, Gralow JR. Resource-stratifiedguideline-basedcancercareshouldbeapriority: Historicalcontextandexamplesofsuccess. Am Soc Clin Oncol Educ Book.2020;40:217-226.
  22. 22. Jacobs J, Hardy L, Semret M, Lunguya O, Phe T, Affolabi D, Yansouni C, Vandenberg O. Diagnosticbacteriologyindistricthospitalsinsub-Saharan Africa: attheforefrontofthecontainmentofantimicrobialresistance. Front Med(Lausanne\.2019;6:205.
  23. 23. Jones A, Rahman RJ, Jiaqing O. Acrisisinthecountryside: Barrierstonurserecruitmentandretentioninruralareasofhigh-incomecountries: Aqualitativemeta-analysis. JRural Stud.2019;72:153-163.
  24. 24. Kilmarx PH, Katz F, Razak MH, Palen J, Cheever LW, International Journalof Multidisciplinary Researchand Growth Evaluationwww. allmultidisciplinaryjournal. com783|Page Glass RI. Themedicaleducationpartnershipinitiative: Strengtheninghumanresourcestoend AIDSandimprovehealthin Africa. Acad Med.2019;94(11\:1704-1713.
  25. 25. Klingholz R, S?tterlin S, Kaps A, Hinz C. Leapfrogging Africa: Sustainable Innovationin Health, Educationand Agriculture. African Sun Media;2020.
  26. 26. Kundrod KA, Smith CA, Hunt B, Schwarz RA, Schmeler K, Richards-Kortum R. Advancesintechnologiesforcervicalcancerdetectioninlow-resourcesettings. Expert Rev Mol Diagn.2019;19(8\:695-714.
  27. 27. Kyomuhendo C, Adeola R. Greenandgrey: Nutritionallifestyleandhealthfulageinginruralandurbanareasofthree Sub-Saharan Africancountries. Bus Strat Dev.2021;4(1\:22-33.
  28. 28. Laverty H, Meulien P. Theinnovativemedicines-privatecollaboration. Front Med(Lausanne\.2019;6:275.
  29. 29. Liardo RLE, Borz?AM, Spatola C, Martino B, Privitera G, Basile F, etal. Effectsofinfectionsonthepathogenesisofcancer. Indian JMed Res.2021;153(4\:431-445.
  30. 30. Malone ER, Oliva M, Sabatini PJ, Stockley TL, Siu LL. Molecularprofilingforprecisioncancertherapies. Genome Med.2020;12:1-19.
  31. 31. Mandell R, Israel BA, Schulz AJ. Breakingfreefromsiloes: Intersectionalityasacollectiveactionframetoaddresstoxicexposuresandreproductivehealth. Soc Mov Stud.2019;18(3\:346-363.
  32. 32. Mboowa G, Sserwadda I, Aruhomukama D. Genomicsandbioinformaticscapacityin Africa: Nocontinentisleftbehind. Genome.2021;64(5\:503-513.
  33. 33. Mein SA. COVID-19andhealthdisparities: Thereality2020;35(8\:2439-2440.
  34. 34. Munung NS, Ambele MA, Moela P. Advancingglobalequityincancergenomicschallengesandopportunitiesin Sub-Saharan Africa. Curr Opin Genet Dev.2021;66:20-24.
  35. 35. Murphy AB, Jordan-Bychkov TG, Jordan BB. The European Culture Area: ASystematic Geography. Rowman&Littlefield Publishers;2020.
  36. 36. Mutebi M, Anderson BO, Duggan C, Adebamowo C, Agarwal G, Ali Z, etal. Breastcancertreatment: Aphasedapproachtoimplementation. Cancer.2020;126:2365-2378.
  37. 37. Okitasari M, Prabowo MH, Santono H. Multi-stakeholderpartnerships: Atangibleinstrumenttosupporttheimplementationofthe2030agendaatthelocallevel. Soc Dev Issues.2021;42(3\:61-86.
  38. 38. Okonta KE, Echieh PC, Abubakar U, Baiyewu LA, Nzewi OC. Managementoflungcancerin Africa: Underdiagnosisandpooraccesstotreatment Acloselookat Nigeriaand West African Sub-region. JPan Afr Thorac Soc.2021;2(3\:122-129.
  39. 39. Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, etal. Personalizedearlydetectionandpreventionofbreastcancer: ENVISIONconsensusstatement. Nat Rev Clin Oncol.2020;17(11\:687-705.
  40. 40. Sundar S. Leveragingservicedesignforhealthcaretransformation: Towardpeople-centered, integrated, andtechnology-enabledhealthcaresystems. JServ Manag.2020;31(5\:889-909.
  41. 41. Penedo FJ, Oswald LB, Kronenfeld JP, Garcia SF, Cella D, Yanez B. Theincreasingvalueofe Healthinthedeliveryofpatient-centredcancercare. Lancet Oncol.2020;21(5\: e240-e251.
  42. 42. Qoronfleh MW, Chouchane L, Mifsud B, Al Emadi M, Ismail S. THEFUTUREOFMEDICINE: Healthcareinnovationthroughprecisionmedicine: Policycasestudyof Qatar. Life Sci Soc Policy.2020;16:1-20.
  43. 43. Rahman R, Clark MD, Collins Z, Traore F, Dioukhane EM, Thiam H, etal. Cervicalcancerscreeningdecentralizedpolicyadaptation: An Africanrural-context-specificsystematicliteraturereview. Glob Health Action.2019;12(1\:1587894.
  44. 44. Raijada D, Wac K, Greisen E, Rantanen J, Genina N. Integrationofpersonalizeddrugdeliverysystemsintodigitalhealth. Adv Drug Deliv Rev.2021;176:113857.
  45. 45. Shui L, Ren H, Yang X, Li J, Chen Z, Yi C, etal. Theeraofradiogenomicsinprecisionmedicine: Anemergingapproachtosupportdiagnosis, treatmentdecisions, andprognosticationinoncology. Front Oncol.2021;10:570465.
  46. 46. Sutton AL, He J, Tanner E, Edmonds MC, Henderson A, de Mendoza AH, etal. Understandingmedicalmistrustin Blackwomenatriskof BRCA1/2mutations. JHealth Dispar Res Pract.2019;12(3\:35.
  47. 47. Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Reviewofprecisioncancermedicine: Evolutionofthetreatmentparadigm. Cancer Treat Rev.2020;86:102019.
  48. 48. Valle L, Vilar E, Tavtigian SV, Stoffel EM. Geneticpredispositiontocolorectalcancer: Syndromes, genes, classificationofgeneticvariantsandimplicationsforprecisionmedicine. JPathol.2019;247(5\:574-588.
  49. 49. Wells JC, Sharma S, Del Paggio JC, Hopman WM, Gyawali B, Mukherji D, etal. Ananalysisofcontemporaryoncologyrandomizedclinicaltrialsfromlow/middle-incomevshigh-incomecountries. JAMAOncol.2021;7(3\:379-385.
  50. 50. Winkfield KM, Regnante JM, Miller-Sonet E, Gonz?lez ET, Freund KM, Doykos PM. Developmentofanactionableframeworktoaddresscancercaredisparitiesinmedicallyunderservedpopulationsinthe United States: Expertroundtablerecommendations. JCOOncol Pract.2021;17(3\: e278-e293.
  51. 51. Xu J, Yang P, Xue S, Sharma B, Sanchez-Martin M, Wang F, etal. Translatingcancergenomicsintoprecisionmedicinewithartificialintelligence: Applications, challengesandfutureperspectives. Hum Genet.2019;138(2\:109-124.
  52. 52. Yurkovich JT, Tian Q, Price ND, Hood L. Asystemsapproachtoclinicaloncologyusesdeepphenotypingtodeliverpersonalizedcare. Nat Rev Clin Oncol.2020;17(3\:183-194.

Share This Article: